Search

Filters

Clear Filters
8:20 AM - 8:25 AM ET

1220 - Salvage High-Dose-Rate Brachytherapy after Prior Prostate Radiotherapy: Contemporary Multi-Institutional Outcomes in 236 Patients
Speaker: Bilski, Mateusz, MD, PhD - Lublin Region Oncology Center, Lublin
8:25 AM - 8:30 AM ET

1221 - MRI-Guided Risk-Adaptive High Dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: A Phase II Trial
Speaker: Thomsen, Bryce, MD - Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA
8:30 AM - 8:35 AM ET

1222 - A Prospective Single-Arm Study of POSLUMA PET in Very Low Prostate-Specific Antigen Recurrence Following Prostatectomy
Speaker: Hogan, Jacob, MD - Harvard Radiation Oncology Program, Boston, MA
8:05 AM - 8:10 AM ET

1223 - Impact of Risk of New-Lesion Progression on Benefit of Local Consolidative Therapy in Immunotherapy-Treated Patients with Advanced Non-Small Cell Lung Cancer
Speaker: Chen, Hongru - Fudan University Shanghai Cancer Center, Shanghai, DC
8:10 AM - 8:15 AM ET

1224 - Role of Consolidation Radiotherapy in Mutation-Positive vs. Mutation-Negative Patients with Stage 4 Oligopersistent NSCLC
Speaker: Ray, Amitabh, MD, MBBS, DNB - Chittaranjan National Cancer Institute, Kolkata, West Benga
8:15 AM - 8:20 AM ET

1225 - Are Some "New" Lung Metastases Already Present at Baseline? An Artificial Intelligence-Based Re-evaluation in Patients Undergoing Lung SBRT for Oligometastases
Speaker: Ko, Heejoo, MD, BS - College of Medicine, The Catholic University of Korea, Seoul, SEO
8:20 AM - 8:25 AM ET

1226 - Feasibility of Aumolertinib followed by SRT in EGFR+ NSCLC Patients with Intracranial Oligo-Progression: A Phase II, Prospective Study
Speaker: Li, Huiting, MS - Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, Shanghai
8:25 AM - 8:30 AM ET

1227 - Feasibility and Short-Term Outcomes after One Fraction, Simulation-Free CT-Guided Stereotactic Adaptive Radiotherapy for Patients with Oligometastatic and Primary Lung Tumors (ONE STOP)
Speaker: D'Souza, Alden, MD, MPHS - Washington University in St. Louis School of Medicine, St Louis, MO
8:30 AM - 8:35 AM ET

1228 - Immuno-EclipseRT (iERT): An Immune-Adaptive Heterogeneous Radiotherapy Strategy Triggers XCL1<sup>+ </sup>NK-driven CD8? T Cell Immunity Against Bulky Tumors
Speaker: Luo, Ren, MD, PhD - West China Hospital of Sichuan University, Chengdu, Sichuan
8:05 AM - 8:10 AM ET

1229 - Effect of a Novel Quantitative Cone Beam CT Technique on Soft Tissue Boundary Visualization: A Prospective Interobserver Study
Speaker: Altunbas, Cem, PhD - Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO
3:20 PM - 3:30 PM ET

123 - Clonal Hematopoiesis Following Radiation Therapy as a Novel Predictor of Cancer Control and Survival: Analyses from Prospective Trials
Speaker: Nead, Kevin, MD, MPhil - The University of Texas MD Anderson Cancer Center, Houston, TX
8:10 AM - 8:15 AM ET

1230 - Dynamic CT Reconstruction Using a Latent Diffusion Model Integrating Physical Mechanisms and Population-Individual Collaborative Fine-Tuning
Speaker: Feng, Bin, MS, BS - Chongqing University Cancer Hospital, Shapingba, Chongqing